Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant Adolescents
Health-related Quality of Life, Depression and the Impact on Successful Incorporation of Lifestyle Changes in Insulin Resistant Adolescents as Evidenced by Changes in BMI, Waist Circumference and Metabolic Parameters
1 other identifier
observational
78
1 country
1
Brief Summary
The purpose of this study is to assess adolescents with Insulin Resistance Syndrome for quality of life and altered health related issues.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2007
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 26, 2007
CompletedFirst Posted
Study publicly available on registry
June 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedJanuary 6, 2021
January 1, 2021
1 year
June 26, 2007
January 5, 2021
Conditions
Keywords
Interventions
Adolescents will fill out questionnaires regarding quality of life and dealing with diagnosis of Insulin Resistance Syndrome
questionnaire
Eligibility Criteria
Adoslescents treated in Children's Mercy Hospital and Clinic, Endocrine clinic.
You may qualify if:
- Patients 11-17 years of age who are seen in the Insulin Resistance Clinic for the first time
- Historical control: Patients 11-19 years of age seen in the Insulin Resistance Clinic during the prior four months
You may not qualify if:
- Co-morbid syndrome (Downs, Turner's, Prader Willi etc)
- Diagnosis of Type 2 Diabetes
- Taking Metformin before the initial visit
- Taking medication for or diagnosis of a psychiatric condition prior to initial visit
- Developmentally delayed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adrienne Platt, MS, CPNP
Children's Mercy Hospital Kansas City
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2007
First Posted
June 28, 2007
Study Start
June 1, 2007
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
January 6, 2021
Record last verified: 2021-01